Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Cell Signal ; 98: 110412, 2022 10.
Artículo en Inglés | MEDLINE | ID: mdl-35863589

RESUMEN

Doxorubicin (Dox) is a widely used anti-cancer drug that has a significant limitation, which is cardiotoxicity. Its cardiotoxic side effect is dose dependent and occurs through any age. Dox has been known to exert its toxic effect through oxidative stress, but an emerging mechanism is endoplasmic reticulum (ER) stress that activates proapoptotic pathway involving PERK/ATF4/CHOP axis. These stresses lead to dysfunction of myocardium associated with cell death. Although accumulating evidence support their involvement to Dox-induced cardiotoxicity, the mechanism is not well elucidated. Protein arginine methyltransferases 1 (PRMT1) has been known to play a role in cardiomyocyte cell survival through modulation of ER response. In this study, we demonstrate an important role of PRMT1 in Dox-induced cardiotoxicity via ER stress. Depletion of PRMT1 in H9c2 cardiomyocytes enhanced Dox-stimulated cell death, and increased reactive oxygen species (ROS) production and DNA damage by enhancing the levels of proapoptotic cleaved Caspase-3 and γH2AX in response to Dox. Consistently, overexpression of PRMT1 attenuated the apoptotic effect of Dox. In addition, the acute treatment of Dox induced a substantial increase in PRMT1 activity and the translocation of PRMT1 to ER. Overexpression of PRMT1 in cardiomyocyte diminished Dox-induced ER stress, and ATF4 methylation by PRMT1 was involved in the suppression of ER stress. Taken together, our data suggest that PRMT1 is a novel target molecule for protection from Dox-induced cardiotoxicity.


Asunto(s)
Cardiotoxicidad , Estrés del Retículo Endoplásmico , Apoptosis , Cardiotoxicidad/metabolismo , Cardiotoxicidad/prevención & control , Doxorrubicina/toxicidad , Humanos , Metiltransferasas/metabolismo , Metiltransferasas/farmacología , Miocitos Cardíacos/metabolismo , Estrés Oxidativo , Proteína-Arginina N-Metiltransferasas/genética , Proteína-Arginina N-Metiltransferasas/metabolismo , Proteínas Represoras/metabolismo
2.
Cell Mol Life Sci ; 79(2): 99, 2022 Jan 28.
Artículo en Inglés | MEDLINE | ID: mdl-35089423

RESUMEN

Angiotensin II (AngII) has potent cardiac hypertrophic effects mediated through activation of hypertrophic signaling like Wnt/ß-Catenin signaling. In the current study, we examined the role of protein arginine methyltransferase 7 (PRMT7) in cardiac function. PRMT7 was greatly decreased in hypertrophic hearts chronically infused with AngII and cardiomyocytes treated with AngII. PRMT7 depletion in rat cardiomyocytes resulted in hypertrophic responses. Consistently, mice lacking PRMT7 exhibited the cardiac hypertrophy and fibrosis. PRMT7 overexpression abrogated the cellular hypertrophy elicited by AngII, while PRMT7 depletion exacerbated the hypertrophic response caused by AngII. Similar with AngII treatment, the cardiac transcriptome analysis of PRMT7-deficient hearts revealed the alteration in gene expression profile related to Wnt signaling pathway. Inhibition of PRMT7 by gene deletion or an inhibitor treatment enhanced the activity of ß-catenin. PRMT7 deficiency decreases symmetric dimethylation of ß-catenin. Mechanistic studies reveal that methylation of arginine residue 93 in ß-catenin decreases the activity of ß-catenin. Taken together, our data suggest that PRMT7 is important for normal cardiac function through suppression of ß-catenin activity.


Asunto(s)
Cardiomegalia/genética , Miocardio/metabolismo , Miocitos Cardíacos/metabolismo , Proteína-Arginina N-Metiltransferasas/genética , beta Catenina/genética , Angiotensinas , Animales , Cardiomegalia/inducido químicamente , Cardiomegalia/metabolismo , Fibrosis , Perfilación de la Expresión Génica/métodos , Humanos , Masculino , Ratones Endogámicos C57BL , Ratones Noqueados , Ratones Transgénicos , Miocardio/patología , Proteína-Arginina N-Metiltransferasas/deficiencia , RNA-Seq/métodos , Vía de Señalización Wnt/genética , beta Catenina/metabolismo
3.
RNA Biol ; 18(sup2): 640-654, 2021 11 12.
Artículo en Inglés | MEDLINE | ID: mdl-34755591

RESUMEN

The roles of long non-coding RNA (LncRNA) have been highlighted in various development processes including congenital heart defects (CHD). Here, we characterized the molecular function of LncRNA, Moshe (1010001N08ik-203), one of the Gata6 antisense transcripts located upstream of Gata6, which is involved in both heart development and the most common type of congenital heart defect, atrial septal defect (ASD). During mouse embryonic development, Moshe was first detected during the cardiac mesoderm stage (E8.5 to E9.5) where Gata6 is expressed and continues to increase at the atrioventricular septum (E12.5), which is involved in ASD. Functionally, the knock-down of Moshe during cardiogenesis caused significant repression of Nkx2.5 in cardiac progenitor stages and resulted in the increase in major SHF lineage genes, such as cardiac transcriptional factors (Isl1, Hand2, Tbx2), endothelial-specific genes (Cd31, Flk1, Tie1, vWF), a smooth muscle actin (a-Sma) and sinoatrial node-specific genes (Shox2, Tbx18). Chromatin Isolation by RNA Purification showed Moshe activates Nkx2.5 gene expression via direct binding to its promoter region. Of note, Moshe was conserved across species, including human, pig and mouse. Altogether, this study suggests that Moshe is a heart-enriched lncRNA that controls a sophisticated network of cardiogenesis by repressing genes in SHF via Nkx2.5 during cardiac development and may play an important role in ASD.


Asunto(s)
Diferenciación Celular/genética , Linaje de la Célula/genética , Miocitos Cardíacos/metabolismo , ARN Largo no Codificante/genética , Animales , Línea Celular , Elementos de Facilitación Genéticos , Factor de Transcripción GATA6/genética , Perfilación de la Expresión Génica , Regulación del Desarrollo de la Expresión Génica , Técnicas de Silenciamiento del Gen , Humanos , Mesodermo/embriología , Mesodermo/metabolismo , Ratones , Mioblastos Cardíacos/citología , Mioblastos Cardíacos/metabolismo , Miocitos Cardíacos/citología , Organogénesis/genética , Regiones Promotoras Genéticas , Interferencia de ARN , ARN sin Sentido
4.
Exp Mol Med ; 53(10): 1569-1579, 2021 10.
Artículo en Inglés | MEDLINE | ID: mdl-34635781

RESUMEN

Vascular smooth muscle cells (VSMCs) have remarkable plasticity in response to diverse environmental cues. Although these cells are versatile, chronic stress can trigger VSMC dysfunction, which ultimately leads to vascular diseases such as aortic aneurysm and atherosclerosis. Protein arginine methyltransferase 1 (Prmt1) is a major enzyme catalyzing asymmetric arginine dimethylation of proteins that are sources of asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase. Although a potential role of Prmt1 in vascular pathogenesis has been proposed, its role in vascular function has yet to be clarified. Here, we investigated the role and underlying mechanism of Prmt1 in vascular smooth muscle contractility and function. The expression of PRMT1 and contractile-related genes was significantly decreased in the aortas of elderly humans and patients with aortic aneurysms. Mice with VSMC-specific Prmt1 ablation (smKO) exhibited partial lethality, low blood pressure and aortic dilation. The Prmt1-ablated aortas showed aortic dissection with elastic fiber degeneration and cell death. Ex vivo and in vitro analyses indicated that Prmt1 ablation significantly decreased the contractility of the aorta and traction forces of VSMCs. Prmt1 ablation downregulated the expression of contractile genes such as myocardin while upregulating the expression of synthetic genes, thus causing the contractile to synthetic phenotypic switch of VSMCs. In addition, mechanistic studies demonstrated that Prmt1 directly regulates myocardin gene activation by modulating epigenetic histone modifications in the myocardin promoter region. Thus, our study demonstrates that VSMC Prmt1 is essential for vascular homeostasis and that its ablation causes aortic dilation/dissection through impaired myocardin expression.


Asunto(s)
Aneurisma de la Aorta , Disección Aórtica , Anciano , Disección Aórtica/genética , Disección Aórtica/metabolismo , Disección Aórtica/patología , Animales , Aneurisma de la Aorta/metabolismo , Células Cultivadas , Humanos , Ratones , Contracción Muscular , Músculo Liso Vascular , Miocitos del Músculo Liso/metabolismo , Fenotipo , Proteína-Arginina N-Metiltransferasas/genética , Proteína-Arginina N-Metiltransferasas/metabolismo , Proteínas Represoras/genética , Proteínas Represoras/metabolismo
5.
Cell Death Dis ; 11(3): 203, 2020 Mar 23.
Artículo en Inglés | MEDLINE | ID: mdl-32251281

RESUMEN

A correction to this paper has been published and can be accessed via a link at the top of the paper.

6.
J Cachexia Sarcopenia Muscle ; 11(4): 1070-1088, 2020 08.
Artículo en Inglés | MEDLINE | ID: mdl-32096917

RESUMEN

BACKGROUND: Muscle wasting, resulting from aging or pathological conditions, leads to reduced quality of life, increased morbidity, and increased mortality. Much research effort has been focused on the development of exercise mimetics to prevent muscle atrophy and weakness. In this study, we identified indoprofen from a screen for peroxisome proliferator-activated receptor γ coactivator α (PGC-1α) inducers and report its potential as a drug for muscle wasting. METHODS: The effects of indoprofen treatment on dexamethasone-induced atrophy in mice and in 3-phosphoinositide-dependent protein kinase-1 (PDK1)-deleted C2C12 myotubes were evaluated by immunoblotting to determine the expression levels of myosin heavy chain and anabolic-related and oxidative metabolism-related proteins. Young, old, and disuse-induced muscle atrophic mice were administered indoprofen (2 mg/kg body weight) by gavage. Body weight, muscle weight, grip strength, isometric force, and muscle histology were assessed. The expression levels of muscle mass-related and function-related proteins were analysed by immunoblotting or immunostaining. RESULTS: In young (3-month-old) and aged (22-month-old) mice, indoprofen treatment activated oxidative metabolism-related enzymes and led to increased muscle mass. Mechanistic analysis using animal models and muscle cells revealed that indoprofen treatment induced the sequential activation of AKT/p70S6 kinase (S6K) and AMP-activated protein kinase (AMPK), which in turn can augment protein synthesis and PGC-1α induction, respectively. Structural prediction analysis identified PDK1 as a target of indoprofen and, indeed, short-term treatment with indoprofen activated the PDK1/AKT/S6K pathway in muscle cells. Consistent with this finding, PDK1 inhibition abrogated indoprofen-induced AKT/S6K activation and hypertrophic response. CONCLUSIONS: Our findings demonstrate the effects of indoprofen in boosting skeletal muscle mass through the sequential activation of PDK1/AKT/S6K and AMPK/PGC-1α. Taken together, our results suggest that indoprofen represents a potential drug to prevent muscle wasting and weakness related to aging or muscle diseases.


Asunto(s)
Inhibidores de la Ciclooxigenasa/uso terapéutico , Indoprofeno/uso terapéutico , Atrofia Muscular/tratamiento farmacológico , Proteínas Proto-Oncogénicas c-akt/metabolismo , Animales , Inhibidores de la Ciclooxigenasa/farmacología , Humanos , Indoprofeno/farmacología , Masculino , Ratones
7.
Cell Death Dis ; 10(12): 903, 2019 12 02.
Artículo en Inglés | MEDLINE | ID: mdl-31787756

RESUMEN

Endoplasmic reticulum (ER) stress signaling plays a critical role in the control of cell survival or death. Persistent ER stress activates proapoptotic pathway involving the ATF4/CHOP axis. Although accumulating evidences support its important contribution to cardiovascular diseases, but its mechanism is not well characterized. Here, we demonstrate a critical role for PRMT1 in the control of ER stress in cardiomyocytes. The inhibition of PRMT1 augments tunicamycin (TN)-triggered ER stress response in cardiomyocytes while PRMT1 overexpression attenuates it. Consistently, PRMT1 null hearts show exacerbated ER stress and cell death in response to TN treatment. Interestingly, ATF4 depletion attenuates the ER stress response induced by PRMT1 inhibition. The methylation-deficient mutant of ATF4 with the switch of arginine 239 to lysine exacerbates ER stress accompanied by enhanced levels of proapoptotic cleaved Caspase3 and phosphorylated-γH2AX in response to TN. The mechanistic study shows that PRMT1 modulates the protein stability of ATF4 through methylation. Taken together, our data suggest that ATF4 methylation on arginine 239 by PRMT1 is a novel regulatory mechanism for protection of cardiomyocytes from ER stress-induced cell death.


Asunto(s)
Factor de Transcripción Activador 4/metabolismo , Estrés del Retículo Endoplásmico , Miocitos Cardíacos/metabolismo , Proteína-Arginina N-Metiltransferasas/metabolismo , Factor de Transcripción Activador 4/química , Factor de Transcripción Activador 4/genética , Secuencia de Aminoácidos , Animales , Animales Recién Nacidos , Apoptosis/efectos de los fármacos , Línea Celular , Estrés del Retículo Endoplásmico/efectos de los fármacos , Humanos , Metilación/efectos de los fármacos , Mutación/genética , Miocitos Cardíacos/efectos de los fármacos , Especificidad de Órganos , Unión Proteica/efectos de los fármacos , Proteína-Arginina N-Metiltransferasas/antagonistas & inhibidores , Ratas , Factor de Transcripción CHOP/metabolismo , Tunicamicina/farmacología , Regulación hacia Arriba/efectos de los fármacos
8.
Nat Commun ; 9(1): 5107, 2018 11 30.
Artículo en Inglés | MEDLINE | ID: mdl-30504773

RESUMEN

Dysregulation of Ca2+/calmodulin-dependent protein kinase (CaMK)II is closely linked with myocardial hypertrophy and heart failure. However, the mechanisms that regulate CaMKII activity are incompletely understood. Here we show that protein arginine methyltransferase 1 (PRMT1) is essential for preventing cardiac CaMKII hyperactivation. Mice null for cardiac PRMT1 exhibit a rapid progression to dilated cardiomyopathy and heart failure within 2 months, accompanied by cardiomyocyte hypertrophy and fibrosis. Consistently, PRMT1 is downregulated in heart failure patients. PRMT1 depletion in isolated cardiomyocytes evokes hypertrophic responses with elevated remodeling gene expression, while PRMT1 overexpression protects against pathological responses to neurohormones. The level of active CaMKII is significantly elevated in PRMT1-deficient hearts or cardiomyocytes. PRMT1 interacts with and methylates CaMKII at arginine residues 9 and 275, leading to its inhibition. Accordingly, pharmacological inhibition of CaMKII restores contractile function in PRMT1-deficient mice. Thus, our data suggest that PRMT1 is a critical regulator of CaMKII to maintain cardiac function.


Asunto(s)
Proteína Quinasa Tipo 2 Dependiente de Calcio Calmodulina/metabolismo , Insuficiencia Cardíaca/etiología , Insuficiencia Cardíaca/metabolismo , Miocardio/metabolismo , Proteína-Arginina N-Metiltransferasas/metabolismo , Animales , Proteína Quinasa Tipo 2 Dependiente de Calcio Calmodulina/genética , Línea Celular , Ecocardiografía , Electrocardiografía , Electrofisiología , Insuficiencia Cardíaca/genética , Humanos , Inmunohistoquímica , Ratones , Ratones Noqueados , Miocardio/patología , Miocitos Cardíacos/metabolismo , Miocitos Cardíacos/patología , Proteína-Arginina N-Metiltransferasas/genética
9.
Proc Natl Acad Sci U S A ; 114(8): E1345-E1354, 2017 02 21.
Artículo en Inglés | MEDLINE | ID: mdl-28154134

RESUMEN

On pathological stress, Wnt signaling is reactivated and induces genes associated with cardiac remodeling and fibrosis. We have previously shown that a cell surface receptor Cdon (cell-adhesion associated, oncogene regulated) suppresses Wnt signaling to promote neuronal differentiation however its role in heart is unknown. Here, we demonstrate a critical role of Cdon in cardiac function and remodeling. Cdon is expressed and predominantly localized at intercalated disk in both mouse and human hearts. Cdon-deficient mice develop cardiac dysfunction including reduced ejection fraction and ECG abnormalities. Cdon-/- hearts exhibit increased fibrosis and up-regulation of genes associated with cardiac remodeling and fibrosis. Electrical remodeling was demonstrated by up-regulation and mislocalization of the gap junction protein, Connexin 43 (Cx43) in Cdon-/- hearts. In agreement with altered Cx43 expression, functional analysis both using Cdon-/- cardiomyocytes and shRNA-mediated knockdown in rat cardiomyocytes shows aberrant gap junction activities. Analysis of the underlying mechanism reveals that Cdon-/- hearts exhibit hyperactive Wnt signaling as evident by ß-catenin accumulation and Axin2 up-regulation. On the other hand, the treatment of rat cardiomyocytes with a Wnt activator TWS119 reduces Cdon levels and aberrant Cx43 activities, similarly to Cdon-deficient cardiomyocytes, suggesting a negative feedback between Cdon and Wnt signaling. Finally, inhibition of Wnt/ß-catenin signaling by XAV939, IWP2 or dickkopf (DKK)1 prevented Cdon depletion-induced up-regulation of collagen 1a and Cx43. Taken together, these results demonstrate that Cdon deficiency causes hyperactive Wnt signaling leading to aberrant intercellular coupling and cardiac fibrosis. Cdon exhibits great potential as a target for the treatment of cardiac fibrosis and cardiomyopathy.


Asunto(s)
Moléculas de Adhesión Celular/deficiencia , Corazón/fisiología , Remodelación Ventricular/fisiología , Vía de Señalización Wnt/fisiología , beta Catenina/metabolismo , Animales , Moléculas de Adhesión Celular/metabolismo , Conexina 43/metabolismo , Conexinas/metabolismo , Fibrosis/metabolismo , Uniones Comunicantes/metabolismo , Ratones , Ratones Endogámicos C57BL , Miocardio/metabolismo , Miocitos Cardíacos/metabolismo , Pirimidinas/metabolismo , Pirroles/metabolismo , Ratas , Ratas Sprague-Dawley , Regulación hacia Arriba/fisiología
10.
J Adv Prosthodont ; 8(2): 94-100, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-27141252

RESUMEN

PURPOSE: To evaluate the effects of hydrogen peroxide pretreatment and heat activation of silane on the shear bond strength of fiber-reinforced composite posts to resin cement. MATERIALS AND METHODS: The specimens were prepared to evaluate the bond strength of epoxy resin-based fiber posts (D.T. Light-Post) to dual-curing resin cement (RelyX U200). The specimens were divided into four groups (n=18) according to different surface treatments: group 1, no treatment; group 2, silanization; group 3, silanization after hydrogen peroxide etching; group 4, silanization with warm drying at 80℃ after hydrogen peroxide etching. After storage of the specimens in distilled water at 37℃ for 24 hours, the shear bond strength (in MPa) between the fiber post and resin cement was measured using a universal testing machine. The fractured surface of the fiber post was examined using scanning electron microscopy. Data were analyzed using one-way ANOVA and post-hoc analysis with Tukey's HSD test (α=0.05). RESULTS: Silanization of the fiber post (Group 2) significantly increased the bond strength in comparison with the non treated control (Group 1) (P<.05). Heat drying after silanization also significantly increased the bond strength (Group 3 and 4) (P<.05). However, no effect was determined for hydrogen peroxide etching before applying silane agent (Group 2 and 3) (P>.05). CONCLUSION: Fiber post silanization and subsequent heat treatment (80℃) with warm air blower can be beneficial in clinical post cementation. However, hydrogen peroxide etching prior to silanization was not effective in this study.

11.
Clin Oral Implants Res ; 24(8): 890-5, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-22220715

RESUMEN

AIM: The purposes of this study were (1) to investigate the bucco-lingual course of the mandibular canal in the bony structure and (2) to figure out the relationship between the position of mental foramen on panoramic radiographs and the horizontal course of the mandibular canal. MATERIALS AND METHODS: A database of panoramic radiography and spiral computed tomography (CT) scans was searched and 100 subjects were selected based on the criteria. Mental foramina were classified into four groups according to its antero-posterior position. Three measurements were made on each slice of coronal CT scans at three different points: (1) apex of second premolar; (2) median point of two root apexes of first molar; and (3) median point of two root apexes of second molar. The bucco-lingual ratios were calculated to access the relative bucco-lingual position of the mandibular canal. RESULTS: The distribution of subjects according to the type of mental foramen was: (1) type 3, 67%; (2) type 2, 26%; (3) type 4, 5%; and (4) type 1, 2%. The overall horizontal course of the mandibular canal was relatively constant from the second molar to first molar, whereas much significant directional change was found on the remaining course. Between types 2 and 3, no statistically significant differences were found at the level of the second molar and first molar (P = 0.461 and 0.965, respectively). Only below the second premolar, significant differences were found (P = 0.001). CONCLUSIONS: Based on the findings of our computed tomographic image analysis, the position of mental foramen on panoramic radiographs was affected by its horizontal course of inferior alveolar nerve. The significant horizontal direction change of the course was found after the canal passing below the mandibular first molar regardless of the antero-posterior position of mental foramen.


Asunto(s)
Mandíbula/diagnóstico por imagen , Radiografía Panorámica/métodos , Tomografía Computarizada Espiral/métodos , Adulto , Anciano , Diente Premolar/diagnóstico por imagen , Cefalometría/métodos , Femenino , Humanos , Masculino , Mandíbula/anatomía & histología , Nervio Mandibular/anatomía & histología , Nervio Mandibular/diagnóstico por imagen , Persona de Mediana Edad , Diente Molar/diagnóstico por imagen , Radiografía Panorámica/instrumentación , Ápice del Diente/diagnóstico por imagen , Pantallas Intensificadoras de Rayos X , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA